Test Drive Our New Site! We have some improvements in the works that we're excited for you to experience. Click here to try our new, faster, mobile friendly beta site. We will be maintaining our current version of the site thru the end of 2024, so you can switch back as our improvements continue.
Legislation Quick Search
04/23/2024 03:54 PM
Pennsylvania State Senate
https://www.legis.state.pa.us/cfdocs/Legis/CSM/showMemoPublic.cfm?chamber=S&SPick=20130&cosponId=9865
Share:
Home / Senate Co-Sponsorship Memoranda

Senate Co-Sponsorship Memoranda

Subscribe to PaLegis Notifications
NEW!

Subscribe to receive notifications of new Co-Sponsorship Memos circulated

By Member | By Date | Keyword Search


Senate of Pennsylvania
Session of 2013 - 2014 Regular Session

MEMORANDUM

Posted: December 7, 2012 01:13 PM
From: Senator Kim L. Ward
To: All Senate members
Subject: Memo #16 – Prescription drug clearinghouse
 
I plan to introduce legislation to establish a prescription drug clearinghouse to track prescription drugs prescribed to ensure that patients are being treated for medical reasons. Pain clinics will be regulated by the Department of Health.

Pill mills and prescription drug abuse are a national problem, and many states are passing laws to deal with this increasingly prevalent problem. My legislation is modeled after Florida’s recent “Pill Mill” law, which has been touted as a success in that state.

Clinics will be required to submit to annual inspections by the Department of Health and pain clinic physicians must complete specialized training. However, the bill provides safeguards for legitimate physicians that are dispensing medications to ensure that the medical profession is protected from unnecessary government oversight and malicious prosecutions.

Under the bill, an electronic clearinghouse will require that all controlled substance prescriptions be recorded into a database. This will make it easier to monitor drugs that are abused like oxycodone. The pharmacy dispensing the controlled substance must electronically enter into a database, information that includes: the name of the prescribing practitioner with their federal DEA registration number; the date the prescription was filled as well as the method of payment; the full name, address and date of birth for the whom the prescription was written; the name, national drug code, quantity and strength of the controlled substance dispensed and other appropriate identifying information. All data must be entered into the system as soon as possible but not more than 7 days after the date the drug is dispensed. Intentional, unauthorized use of the database is considered a felony of the third degree, punishable by a civil penalty and all appropriate licensing act penalties. Persons who willfully and knowingly fail to report the dispensing of a controlled substance as required by this act will face fines and criminal penalties.

If you have any questions regarding this legislation, please do not hesitate to contact my office at 717-787-6063.



Introduced as SB423